Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Local ablative therapy (LAT) for oligoprogressive, EGFR-mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib.
PaperCitations, authors & open-access status
Local ablative therapy (LAT) for oligoprogressive, EGFR-mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 7 citations, 2018 year and closed oa status.
7
Citations
2018
Year
closed
OA Status